semaglutide bone loss GLP-1s and Health: What the Evidence Says About Semaglutide, Bone Density, and Muscle Is Ozempic (semaglutide) causing bone

Glucose-Dependent Insulinotropic Polypeptide Inhibits Cardiac Hypertrophy and Fibrosis in Diabetic Mice via Suppression of TGF-2

Serious hypersensitivity reactions including anaphylaxis and angioedema have been reported with Ozempic Warnings and Precautions Risk of Thyroid C-Cell Tumors: Patients should be further evaluated if serum calcitonin is measured and found to be elevated or thyroid nodules are noted on physical examination or neck imaging Acute Pancreatitis: Acute pancreatitis, including fatal and nonfatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists, including semaglutide

Check our guide on retatrutide availability for the latest status updates

A cultural phenomenon Beyond medicine and economics, GLP-1 drugs are reshaping body norms

More research is needed, but some studies have found that people with depression or any source of psychological stress can have higher ghrelin (hunger) levels

Stay Informed Subscribe to the ISMP Canada Safety Bulletins and Newsletters